Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 16413659)

1.

Watchful waiting policy in recurrent Ta G1 bladder tumors.

Gofrit ON, Pode D, Lazar A, Katz R, Shapiro A.

Eur Urol. 2006 Feb;49(2):303-6; discussion 306-7. Epub 2006 Jan 6.

PMID:
16413659
2.

[Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].

Werner W, Smesny S, Schubert J.

Z Arztl Fortbild Qualitatssich. 2000 Aug;94(6):519-27. Review. German.

PMID:
10996943
3.
4.

[Management of Ta, T1, and in situ bladder carcinoma: what is new?].

Irani J.

Prog Urol. 2008 May;18 Suppl 5:S94-8. doi: 10.1016/S1166-7087(08)72484-9. Review. French.

PMID:
18585634
5.

Neurofibroma of the urinary bladder.

Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG.

Cancer. 1999 Aug 1;86(3):505-13. Review.

PMID:
10430260
6.

Recent advances in the management of superficial bladder tumors.

Fradet Y.

Can J Urol. 2002 Jun;9(3):1544-50. Review.

PMID:
12121579
7.

Bladder cancer: epidemiology, staging and grading, and diagnosis.

Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J.

Urology. 2005 Dec;66(6 Suppl 1):4-34. Review.

PMID:
16399414
8.

[Three cases of the nephrogenic adenoma of the bladder].

Kajita Y, Mizutani Y, Okuno H, Kakehi Y, Terachi T, Yoshida O.

Hinyokika Kiyo. 1998 Sep;44(9):667-70. Review. Japanese.

PMID:
9805674
9.

Active surveillance for low-risk bladder cancer.

Tiu A, Jenkins LC, Soloway MS.

Urol Oncol. 2014 Jan;32(1):33.e7-10. doi: 10.1016/j.urolonc.2012.12.003. Epub 2013 Mar 19. Review.

PMID:
23518309
10.

[Two cases of the nephrogenic adenoma of the bladder].

Okada Y, Arakaki R, Kitahara M, Terada N, Kaneko Y, Oomori K, Nishimura K.

Hinyokika Kiyo. 2005 Jul;51(7):467-70. Review. Japanese.

PMID:
16119812
11.

Verrucous carcinoma of the bladder.

Horner SA, Fisher HA, Barada JH, Eastman AY, Migliozzi J, Ross JS.

J Urol. 1991 Jun;145(6):1261-3. Review.

PMID:
2033707
12.

[What is the role of active surveillance for small renal masses?].

Maurin C, Vidal F, Lechevallier E.

Prog Urol. 2011 Dec;21(13):895-900. doi: 10.1016/j.purol.2011.08.039. Epub 2011 Oct 26. Review. French.

PMID:
22118353
13.

[Development of bladder cancer chemoprevention].

Dai G, Wang X.

Wei Sheng Yan Jiu. 2003 Mar;32(2):159-62. Review. Chinese.

PMID:
12793013
14.

Growth kinetics and active surveillance for small renal masses.

Lane BR, Tobert CM, Riedinger CB.

Curr Opin Urol. 2012 Sep;22(5):353-9. doi: 10.1097/MOU.0b013e328355ecdf. Review.

PMID:
22706068
15.

Chronic lymphocytic leukemia of the bladder: an atypical etiology of gross hematuria.

Desai V, Isharwal S, Pooli A, Lele S, Feloney M.

Ther Adv Urol. 2014 Oct;6(5):198-200. doi: 10.1177/1756287214535461. Review.

16.

[Diagnosis of infiltrating tumor of the bladder].

Bouchot O, Zerbib M.

Prog Urol. 2002 Nov;12(5):769-72. Review. French. No abstract available.

PMID:
12536904
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk